^
BIOMARKER:

EGFR wild-type

i
Other names: EGFR, ERBB, ERBB1, Epidermal growth factor receptor
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
EGFR wild-type
Non Small Cell Lung Cancer
atezolizumab
Sensitive
:
C3
Nat Med - 2 weeks - (New C3)
EGFR wild-type
Lung Non-Squamous Non-Small Cell Cancer
atezolizumab
Sensitive
:
B
Cancer Med - 3 weeks - (New B)
EGFR wild-type
Non Small Cell Lung Cancer
anlotinib
Sensitive
:
C2
ESMO 2022 - 3 weeks - (New C3)
EGFR wild-type
Non Small Cell Lung Cancer
durvalumab
Sensitive
:
B
EGFR wild-type
Lung Non-Squamous Non-Small Cell Cancer
docetaxel + BPI 2358
Sensitive
:
B
EGFR wild-type
Lung Non-Small Cell Squamous Cancer
cemiplimab
Sensitive
:
B
EGFR wild-type
Lung Non-Squamous Non-Small Cell Cancer
cemiplimab
Sensitive
:
B
EGFR wild-type
Lung Adenocarcinoma
rivoceranib
Sensitive
:
C2
EGFR wild-type
Non Small Cell Lung Cancer
rivoceranib
Sensitive
:
C2
EGFR wild-type
Non Small Cell Lung Cancer
erlotinib
Sensitive
:
C2
EGFR wild-type
Non Small Cell Lung Cancer
pembrolizumab
Sensitive
:
C2
EGFR wild-type
Non Small Cell Lung Cancer
nivolumab
Sensitive
:
C2
EGFR wild-type
Non Small Cell Lung Cancer
toripalimab
Sensitive
:
C2
EGFR wild-type
Non Small Cell Lung Cancer
pemetrexed
Sensitive
:
C3
EGFR wild-type
Non Small Cell Lung Cancer
cabozantinib tablet
Sensitive
:
C3
EGFR wild-type
Non Small Cell Lung Cancer
erlotinib + cabozantinib tablet
Sensitive
:
C3
EGFR wild-type
Lung Non-Squamous Non-Small Cell Cancer
tislelizumab
Sensitive
:
C3
EGFR wild-type
Non Small Cell Lung Cancer
PD1 inhibitor
Sensitive
:
C3
EGFR wild-type
Non Small Cell Lung Cancer
AK112
Sensitive
:
C3
EGFR wild-type
Lung Adenocarcinoma
REC-4881
Sensitive
:
D
EGFR wild-type
Lung Adenocarcinoma
AZD8330
Sensitive
:
D
EGFR wild-type
Lung Adenocarcinoma
PF-04691502
Sensitive
:
D
EGFR wild-type
Lung Adenocarcinoma
GSK2126458
Sensitive
:
D
EGFR wild-type
Non Small Cell Lung Cancer
RTB101
Sensitive
:
D
EGFR wild-type
Non Small Cell Lung Cancer
gefitinib
Sensitive
:
D